J. Goldman & Co’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.36M | Buy |
979,098
+777,991
| +387% | +$4.26M | 0.13% | 147 |
|
|
2025
Q1 | $1.26M | Sell |
201,107
-336,502
| -63% | -$2.12M | 0.03% | 225 |
|
|
2024
Q4 | $2.21M | Buy |
537,609
+388,692
| +261% | +$1.6M | 0.06% | 201 |
|
|
2024
Q3 | $497K | Hold |
148,917
| – | – | 0.01% | 244 |
|
|
2024
Q2 | $444K | Buy |
148,917
+11,044
| +8% | +$32.9K | 0.01% | 253 |
|
|
2024
Q1 | $476K | Hold |
137,873
| – | – | 0.02% | 223 |
|
|
2023
Q4 | $185K | Hold |
137,873
| – | – | 0.01% | 190 |
|
|
2023
Q3 | $301K | Hold |
137,873
| – | – | 0.01% | 192 |
|
|
2023
Q2 | $330K | Buy |
137,873
+48,685
| +55% | +$116K | 0.01% | 200 |
|
|
2023
Q1 | $165K | Hold |
89,188
| – | – | 0.01% | 224 |
|
|
2022
Q4 | $172K | Hold |
89,188
| – | – | 0.01% | 238 |
|
|
2022
Q3 | $137K | Sell |
89,188
-45,812
| -34% | -$70.4K | 0.01% | 240 |
|
|
2022
Q2 | $379K | Buy |
+135,000
| New | +$379K | 0.02% | 208 |
|